Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #25,301 to #25,350.
- Ethyl methanesulfonate (1 revision)
- Ethyl nitrite (1 revision)
- Ethylamine (1 revision)
- Ethylamphetamine (1 revision)
- Ethylene glycol (data page) (1 revision)
- Ethylene glycol dinitrate (1 revision)
- Ethylenediamine dihydriodide (1 revision)
- Ethylenediamine dihydroiodide (1 revision)
- Ethylisopropyltryptamine (1 revision)
- Ethylmalonic encephalopathy (1 revision)
- Ethylmalonyl-CoA decarboxylase (1 revision)
- Ethylmethylthiambutene (1 revision)
- Ethylparaben (1 revision)
- Eticyclidine (1 revision)
- Etidronate (patient information) (1 revision)
- Etilevodopa (1 revision)
- Etoposide Oral and (1 revision)
- Etoposide Oral and Injection (patient information) (1 revision)
- Etoposide Phosphate (patient information) (1 revision)
- Etoxadrol (1 revision)
- Etoxeridine (1 revision)
- Etrasimod (1 revision)
- Etrimfos (1 revision)
- Etrog (1 revision)
- Ets variant 3 (1 revision)
- Ett (1 revision)
- Eucalyptus (1 revision)
- Eucalyptus globulus (1 revision)
- Euclidean space (1 revision)
- Eugenol (1 revision)
- Euglenozoa (1 revision)
- Euglobulin lysis time (1 revision)
- Eukaryote (1 revision)
- Eukaryotic initiation factor (1 revision)
- Eukaryotic translation initiation factor 4 gamma (1 revision)
- Eukaryotic translation initiation factor 4 gamma 1 (1 revision)
- Eupatorium (1 revision)
- Euphorbia (1 revision)
- Euphorbia lathyris (1 revision)
- Euphorbia peplus (1 revision)
- Euphorbia resinifera (1 revision)
- Euphoria (1 revision)
- Eupnea (1 revision)
- Europain (1 revision)
- European Medicines Agency (1 revision)
- European Pharmacopoeia (1 revision)
- Eustigmatophyte (1 revision)
- Eutherian fetoembryonic defense system (eu-FEDS) hypothesis (1 revision)
- Euthyroid sick syndrome cost-effectiveness of therapy (1 revision)
- Euthyroid sick syndrome future or investigational therapies (1 revision)